Understanding Pharmacoepidemiology

by Yang, Yi; West-Strum, Donna

• ISBN13: 9780071635004
• ISBN10: 0071635009
• Edition: 1st
• Format: Paperback
• Copyright: 2010-12-30
• Publisher: McGraw-Hill Education / Medical

Summary

A foundational textbook covering the concepts and methods of pharmacoepidemiologyPharmacoepidemiologyis a comprehensive textbook that gives pharmacy students a basic understanding of what pharmacoepidemiology is and how it works in clincal practice. Students will get solid grounding in real-life applications of risk assessment, screening, and diagnostic testing. Outstanding learning aids include a glossary, chapter objectives, cases, tables and graphs, and Q&A.Emphasis is placed on determining pharmaceutical care outcomes and identifying potential or real drug-use problemsFeatures Discusses topics required by ACPE Provides a basic understanding of what pharmacoepidemiology is and how it works in practice Readers will also be introduced to public health and epidemiology Offer's outstanding pedagogy, which includes a Glossary, Chapter Objectives, Cases, Tables/Graphs and Q/A Questions. Includes real-life applications of risk assessment, screening and diagnostic testingThorough coverage of the concepts and methods of pharmacoepidemiology Part 1; Chapter 1. What is pharmacoepi; Chapter 2. Why is pharmacoepi important (Importance to pharmacy practice); Chapter 3. Principles of epidemiology applied to the study of drug use; Chapter 4. Study Designs (Observational study, Experimental study, Case report, Meta-analysis); Chapter 5. Data Sources (Pharmacy claims data, Validity of data, Defining exposure, Defining outcomes); Chapter 6. Medication Safety Pharmacovig (Use of pharmacoepi to study beneficial drug effects, Use of pharmacoepi to study adverse drug effects); Chapter 7. Continual Monitoring for Unwanted Drug Effects (Post-marketing surveillance); Chapter 8. Applications in Pharmacy Practice; Part 2; Chapter 9. Medication Adherence; Chapter 10. Statistics in Pharmacoepi; Chapter 11. International Perspective (global drug surveillance); Chapter 12. Other Methodological Issues (Causality, Confounding); Chapter 13. Future Issues; Part 3; Chapter 14. Case Studies or Examples; Chapter 15. Learning Objectives; Glossary; Q & A, Questions; Discussion Questions

Author Biography

Author Profiles

Donna West, Ph.,Ph.D.
University of Mississippi
Chair of Pharmacy Administration
University, MS

Donna West-Strum most recently was associate professor in the Division of Pharmaceutical Evaluation and Policy at the University of Arkansas for Medical Sciences College of Pharmacy. The Germantown, Tenn., native earned her bachelor's degree in pharmacy, master's in pharmaceutical sciences and doctorate in pharmacy administration from UM. In 2007, she completed the Academic Leadership Fellows Program with the American Association of Colleges of Pharmacy.

Her research interests focus on community pharmacy practice and using health behavior theories to study the provision, use and evaluation of pharmaceuticals andpharmacy. West-Strum has published more than 40 articles and presented more than 50 presentations at national meetings. She is active in the American PharmacistsAssociation and the National Community Pharmacists Association. She was the faculty liaison for the NCPA chapter at UAMS and was named NCPA Chapter Adviser of theYear in 2004. She edits the NCPA Digest, a comprehensive financial guide to community pharmacy.

Yi Yang, M.D., Ph.D.
University of Mississippi
School of Pharmacy
Assistant Professor
University, MS

Dr. Yi Yang received is an Assistant Professor of Pharmacy Administration at the University of Mississippi. Yang received her Ph.D from both the University of Tennessee and Peking Union Medical College. She received her M.D. from China Medical University, China.

Table of Contents

1. Introduction to Pharmacoepiedmiology

2. Principles of Epidemiology Applied to the Study of Medication Use

3. Study Designs for Pharmacoepidemiology

4. Using Secondary Data in Pharmacoepidemiology

5. Biostatistics and Pharmacoepidemiology

6. Other Methodological Issues

7. Evaluation of the Pharmaceoepidemiology Literature

8. Medication Utilization Patterns

9. Medication Safety and Pharmacovigilance

10. The FDA Perspective on Postmarket Drug Safety